| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 22.05% | Stephens & Co. | $85 → $87 | Maintains | Overweight |
| 08/23/2023 | 15.04% | DA Davidson | → $82 | Initiates Coverage On | → Buy |
| 06/27/2023 | 1.01% | Truist Securities | $60 → $72 | Maintains | Hold |
| 06/23/2023 | -4.6% | RBC Capital | $55 → $68 | Maintains | Sector Perform |
| 06/23/2023 | 15.04% | Raymond James | $70 → $82 | Maintains | Outperform |
| 03/06/2023 | -6% | Barclays | $60 → $67 | Maintains | Equal-Weight |
| 01/24/2023 | -4.6% | Baird | $67 → $68 | Maintains | Outperform |
| 12/12/2022 | -8.81% | Stephens & Co. | $60 → $65 | Maintains | Overweight |
| 12/09/2022 | -18.63% | RBC Capital | $51 → $58 | Maintains | Sector Perform |
| 12/09/2022 | -15.82% | Loop Capital | → $60 | Downgrades | Buy → Hold |
| 09/07/2022 | -35.47% | Truist Securities | $50 → $46 | Downgrades | Buy → Hold |
| 06/24/2022 | -29.85% | Truist Securities | $65 → $50 | Maintains | Buy |
| 06/24/2022 | -22.84% | Baird | $68 → $55 | Maintains | Outperform |
| 06/24/2022 | -1.8% | Raymond James | $72 → $70 | Maintains | Outperform |
| 06/22/2022 | -35.47% | RBC Capital | $73 → $46 | Downgrades | Outperform → Sector Perform |
| 03/18/2022 | -13.02% | Loop Capital | → $62 | Initiates Coverage On | → Buy |
| 12/06/2021 | 1.01% | Raymond James | → $72 | Upgrades | Market Perform → Outperform |
| 12/03/2021 | -4.6% | RBC Capital | $61 → $68 | Maintains | Outperform |
| 12/03/2021 | -14.42% | Barclays | $56 → $61 | Maintains | Equal-Weight |
| 09/08/2021 | -21.44% | Barclays | $49 → $56 | Maintains | Equal-Weight |
| 06/25/2021 | -21.44% | Stephens & Co. | $43 → $56 | Upgrades | Equal-Weight → Overweight |
| 06/25/2021 | -18.63% | Baird | $50 → $58 | Upgrades | Neutral → Outperform |
| 06/25/2021 | -15.82% | RBC Capital | $50 → $60 | Upgrades | Sector Perform → Outperform |
| 11/17/2020 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 11/17/2020 | -49.49% | Barclays | → $36 | Downgrades | Overweight → Equal-Weight |
| 09/04/2020 | -57.91% | Truist Securities | $33 → $30 | Maintains | Buy |
| 09/04/2020 | -57.91% | Raymond James | $28 → $30 | Maintains | Strong Buy |
| 06/26/2020 | -64.93% | Nomura | $17 → $25 | Maintains | Neutral |
| 04/17/2020 | -76.15% | Nomura | $19 → $17 | Maintains | Neutral |
| 04/16/2020 | -62.12% | SunTrust Robinson Humphrey | $33 → $27 | Maintains | Buy |
| 04/07/2020 | -78.96% | RBC Capital | $23 → $15 | Downgrades | Outperform → Sector Perform |
| 03/16/2020 | -66.33% | Raymond James | $30 → $24 | Maintains | Strong Buy |
| 03/06/2020 | -60.72% | Baird | $35 → $28 | Maintains | Neutral |
| 03/06/2020 | -57.91% | Raymond James | $34 → $30 | Maintains | Strong Buy |
| 03/06/2020 | -57.91% | Stephens & Co. | $33 → $30 | Maintains | Overweight |
| 12/06/2019 | -53.7% | Stephens & Co. | $34 → $33 | Maintains | Overweight |
| 12/06/2019 | -50.9% | Baird | $28 → $35 | Maintains | Neutral |
| 09/04/2019 | -53.7% | Barclays | $26 → $33 | Maintains | Overweight |
| 08/30/2019 | -55.11% | SunTrust Robinson Humphrey | $23 → $32 | Maintains | Buy |
| 05/16/2019 | -71.94% | Nomura | $27 → $20 | Downgrades | Buy → Neutral |
What is the target price for GMS (GMS)?
The latest price target for GMS (NYSE: GMS) was reported by Stephens & Co. on September 1, 2023. The analyst firm set a price target for $87.00 expecting GMS to rise to within 12 months (a possible 22.05% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GMS (GMS)?
The latest analyst rating for GMS (NYSE: GMS) was provided by Stephens & Co., and GMS maintained their overweight rating.
When is the next analyst rating going to be posted or updated for GMS (GMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GMS, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GMS was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
Is the Analyst Rating GMS (GMS) correct?
While ratings are subjective and will change, the latest GMS (GMS) rating was a maintained with a price target of $85.00 to $87.00. The current price GMS (GMS) is trading at is $71.28, which is out of the analyst's predicted range.